Columbus, OH –

Today, everything that can be tracked already is – or will be soon. So that begs the question, who does your data belong to? Is it yours, or does somebody else own it? If it’s yours, what are you doing with it? If it isn’t, what are they doing with it? With this flood of data, here are five things we should be asking.

When sharing your sensitive personal data, what if it only existed for a few minutes, and then just disappeared? Is it time to think Snapchat for your personal health data?

What if each individual owned all of their personal data and could grant or deny others “in the moment” access–easily turning it off and on?

What if we created and shared our experiences, not just shared data? Connecting people, not just counted the number of steps they took?

What if you had a personal area network? As you move so moves your data, allowing connections based on your physical location.

What if we could deliver adaptable web/mobile services based on time or real-time data? Sunny outside? Google things to do and get outside results first.

About the Author:

As Managing Director of Innovation and Insights for Syneos Health Communications, Leigh is responsible for building and scaling a global team of healthcare experts who together help life science leaders better understand the complex lives, influences and expectations of their customers. Specifically, they uncover actionable insights that fuel empathy and creativity; lead co-creation events that let marketers learn from peers, trends, and new possibilities; and help clients identify the most valuable and useful new customer experiences to create.

Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for nearly 20 years.She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she held several leadership roles at our largest agency, GSW.  There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business.

Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes.

A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. This year, she led over 250 experts to experts to focus on the most important changes in the commercial, consumer, marketing, digital and healthcare landscapes. (See reports at

Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice and Top 10 Innovation Catalysts of 2017 by MM&M, Leigh also was recognized  as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.